Document and Entity Information
Document and Entity Information | Nov. 13, 2020 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 13, 2020 |
Entity Registrant Name | Constellation Pharmaceuticals, Inc. |
Entity Central Index Key | 0001434418 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity File Number | 001-38584 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 26-1741721 |
Entity Address, Address Line One | 215 First Street |
Entity Address, Address Line Two | Suite 200 |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02142 |
City Area Code | 617 |
Local Phone Number | 714-0555 |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | CNST |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |